TUESDAY, 9 SEPTEMBER 2008 12:30PM-1:30PM

Evolving trends in HTA: Comparing the Evidence
This symposium will compare some of the key markets in terms of their Health Technology Assessment (HTA) structure, the recent activity of the HTA decision making body, the kinds of decisions that have been made, and the likely focus and impact on future health care costs and outcomes.
A framework for comparing "HTA effectiveness" will be put forward and at 2 or more countries will be compared using that framework. Implications for medical innovation, health care quality and cost management will be discussed in light of this analysis.

12.30PM – 12.35PM     Introduction
Jonothan Tierce C.Phil General Manager and Center of Excellence Leader Global Health Economics & Outcomes Research, IMS Health, Falls Church VA, USA

12.35PM – 12.50PM     The Framework for HTA Effectiveness
Jonothan Tierce C.Phil General Manager and Center of Excellence Leader Global Health Economics & Outcomes Research, IMS Health, Falls Church VA, USA
                              
12.50PM – 1.05PM       HTA in South-East Asia
Shu Chuen Li BPharm, MAppSci, MBA, PhD Professor, Chair & Head, Discipline of Pharmacy & Experimental Pharmacology, School of Biomedical Sciences, University of Newcastle, Callaghan, Australia; & Visiting Professor, Department of Pharmacy National University of Singapore, Singapore

1.05PM – 1.15PM         The Australian Perspective                      
Laurence Fong MHP MSc BPharm, Principal Pricing and Market Access, IMS Health, Sydney, NSW, Australia

1.15PM – 1.30PM         Question & Answer/Discussion

Sponsored by IMS Health